Cancer recording in patients with and without type 2 diabetes in the Clinical Practice Research Datalink primary care data and linked hospital admission data: a cohort study.

Autor:	Williams R; CPRD, Medicines and Healthcare Products Regulatory Agency, London, UK.; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., van Staa TP; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Gallagher AM; CPRD, Medicines and Healthcare Products Regulatory Agency, London, UK.; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Hammad T; Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, Maryland, USA.; EMD Serono Research & Development, EMD Serono, Inc, Rockland, Maine, USA., Leufkens HGM; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., de Vries F; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Jazyk:	angličtina
Zdroj:	BMJ open [BMJ Open] 2018 May 26; Vol. 8 (5), pp. e020827. Date of Electronic Publication: 2018 May 26.
DOI:	10.1136/bmjopen-2017-020827
Abstrakt:	Objectives and Setting: Conflicting results from studies using electronic health records to evaluate the associations between type 2 diabetes and cancer fuel concerns regarding potential biases. This study aimed to describe completeness of cancer recording in UK primary care data linked to hospital admissions records. Design: Patients aged 40+ years with insulin or oral antidiabetic prescriptions in Clinical Practice Research Datalink (CPRD) primary care without type 1 diabetes were matched by age, sex and general practitioner practice to non-diabetics. Those eligible for linkage to Hospital Episode Statistics Admitted Patient Care (HES APC), and with follow-up during April 1997-December 2006 were included. Primary and Secondary Outcome Measures: Cancer recording and date of first record of cancer were compared. Characteristics of patients with cancer most likely to have the diagnosis recorded only in a single data source were assessed. Relative rates of cancer estimated from the two datasets were compared. Participants: 53 585 patients with type 2 diabetes matched to 47 435 patients without diabetes were included. Results: Of all cancers (excluding non-melanoma skin cancer) recorded in CPRD, 83% were recorded in HES APC. 94% of cases in HES APC were recorded in CPRD. Concordance was lower when restricted to same-site cancer records, and was negatively associated with increasing age. Relative rates for cancer were similar in both datasets. Conclusions: Good concordance in cancer recording was found between CPRD and HES APC among type 2 diabetics and matched controls. Linked data may reduce misclassification and increase case ascertainment when analysis focuses on site-specific cancers. Competing Interests: Competing interests: All authors confirm that they are not involved in any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in this manuscript. CPRD is owned by the Secretary of State of the UK Department of Health and operates within the MHRA. CPRD has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies. The Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, the private-public funded Top Institute Pharma (www.tipharma.nl, includes cofunding from universities, government and industry), the Dutch Medicines Evaluation Board and the Dutch Ministry of Health. (© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu